Cystadane product information

Introduction

This is a summary of the European Public Assessment Report (EPAR) for Cystadane. It explains how the Medicines Agency assessed the drug to recommend its authorisation in the EU and conditions of use. It is not intended as practical advice on the use of Cystadane.

View product information

Don't miss our upcoming events